Effect of doxycycline on sulfur mustard-induced respiratory lesions in guinea pigs

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 289, Issue 1 33-1, 2005, Pages

  Guignabert, Christophe ^a   Taysse, Laurent ^b   Calvet, Jean Henri ^b   Planus, Emmanuelle ^a   Delamanche, Séraphin ^b   Galiacy, Stéphane ^a   D'Ortho, Marie Pia ^a,c,d  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^b CENTRE D ETUDES DU BOUCHET   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d HENRI MONDOR HOSPITAL   (France)

Author keywords

Blistering agents; Doxycycline; Protease inhibitors; Proteases; Vesicant agents

Indexed keywords

DOXYCYCLINE; GELATINASE; MATRIX METALLOPROTEINASE; MUSTARD GAS; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL TISSUE; ARTICLE; BIOTINYLATION; CONTROLLED STUDY; ENZYME ACTIVITY; GUINEA PIG; IMMUNOBLOTTING; LUNG ALVEOLUS EPITHELIUM; LUNG FLUID; LUNG LAVAGE; LYSIS; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INJURY; ZYMOGRAPHY;

ANIMALS; ANTI-BACTERIAL AGENTS; CHEMICAL WARFARE AGENTS; DOXYCYCLINE; EPITHELIAL CELLS; GELATINASES; GUINEA PIGS; INFLAMMATION; MALE; MUSTARD GAS; PROTEASE INHIBITORS; RESPIRATORY SYSTEM; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 20844462185     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00475.2004     Document Type: Article

References (55)

1. Amin AR, Attur MG, Thakker GD, Patel PD, Vyas PR, Patel RN, Patel IR, and Abramson SB. A novel mechanism of action of tetracyclines: effects on NO synthases. Proc Natl Acad Sci USA 93: 14014-14019, 1996.
2. Amir A, Chapman S, Kadar T, Gozes Y, Sahar R, and Allon N. Sulfur mustard toxicity in macrophages: effect of dexamethasone. J Appl Toxicol 20 Suppl 1: S51-S58, 2000.
3. Amir A, Turetz J, Chapman S, Fishbeine E, Meshulam J, Sahar R, Liani H, Gilat E, Frishman G, and Kadar T. Beneficial effects of topical anti-inflammatory drugs against sulfur mustard-induced ocular lesions in rabbits. J Appl Toxicol 20 Suppl 1: S109-S114, 2000.
4. Anderson DR, Byers SL, and Vesely KR. Treatment' of sulfur mustard (HD)-induced lung injury. J Appl Toxicol 20 Suppl 1: S129-S132, 2000.
5. Babin MC, Ricketts K, Skvorak JP, Gazaway M, Mitcheltree LW, and Casillas RP. Systemic administration of candidate antivesicants to protect against topically applied sulfur mustard in the mouse ear vesicant model (MEVM). J Appl Toxicol 20 Suppl 1: S141-S144, 2000.
6. Bendeck MP. Matrix metalloproteinases: are they antiatherogenic but proaneurysmal? Circ Res 90: 836-837, 2002.
7. Bhattacharya R, Rao PV, Pant SC, Kumar P, Tulsawani RK, Pathak U, Kulkarni A, and Vijayaraghavan R. Protective effects of amifostine and its analogues on sulfur mustard toxicity in vitro and in vivo. Toxicol Appl Pharmacol 176: 24-33, 2001.
8. Bradford M. A rapid sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
9. Braue EH Jr. Development of a reactive topical skin protectant. J Appl Toxicol 19 Suppl 1: S47-S53, 1999.
10. Calvet JH, d'Ortho MP, Jarreau PH, Levame M, Harf A, and Macquin-Mavier I. Glucocorticoids inhibits sulfur mustard-induced airway muscle hyperresponsiveness to substance P. J Appl Physiol 77: 2325-2332, 1994.
11. Calvet JH, Jarreau PH, Levame M, Lorino H, d'Ortho MP, Harf A, and Macquin-Mavier I. Acute and chronic effects of sulfur mustard intoxication in the guinea pig. J Appl Physiol 76: 681-688, 1994.
12. Calvet JH, Planus E, Rouet P, Pezet S, Levame M, Lafuma C, Harf A, and D'Ortho MP. Matrix metalloproteinase gelatinases in sulfur mustard-induced acute airway injury in guinea pigs. Am J Physiol Lung Cell Mol Physiol 276: L754-L762, 1999.
13. Carney DE, Lutz CJ, Picone AL, Gatto LA, Ramamurthy NS, Golub LM, Simon SR, Searles B, Paskanik A, Snyder K, Finck C, Schiller HJ, and Nieman GF. Matrix metalloproteinase inhibitor prevents acute lung injury after cardiopulmonary bypass. Circulation 100: 400-406. 1999.
14. Cowan FM, Broomfield CA, and Smith WJ. Effect of sulfur mustard on protease activity in human peripheral blood lymphocytes. Cell Biol Toxicol 1: 239-248, 1991.
15. Cowan FM, Broomfield CA, and Smith WJ. Suppression of sulfur mustard-increased IL-8 in human keratinocyte cell cultures by serine protease inhibitors: implications for toxicity and medical countermeasures. Cell Biol Toxicol 18: 175-180, 2002.
16. Cowan FM, Yourick JJ, Hurst CG, Broomfield CA, and Smith WJ. Sulfur mustard-increased proteolysis following in vitro and in vivo exposures. Cell Biol Toxicol 9: 269-277, 1993.
17. Delacourt C, d'Ortho MP, Macquin-Mavier I, Pezet S, Harf A, and Lafuma C. Increased 92-kDa gelatinase activity from alveolar macrophages in newborn rats. Am J Respir Crit Care Med 151: 1939-1945, 1995.
18. Dompeling E, Jobsis Q, Vandevijver NM, Wesseling G, and Hendriks H. Chronic bronchiolitis in a 5-yr-old child after exposure to sulphur mustard gas. Eur Respir J 23: 343-346, 2004.
19. Emad A and Rezaian GR. Characteristics of bronchoalveolar lavage fluid in patients with sulfur mustard gas-induced asthma or chronic bronchitis. Am J Med 106: 625-628, 1999.
20. Folgueras AR, Pendas AM, Sanchez LM, and Lopez-Otin C. Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. Int J Dev Biol 48: 411-424, 2004.
21. Freije JM, Baibin M, Pendas AM, Sanchez LM, Puente XS, and Lopez-Otin C. Matrix metalloproteinases and tumor progression. Adv Exp Med Biol 532: 91-107, 2003.
22. Garcia RA, Pantazatos DP, Gessner CR, Go KV, Woods VL Jr, and Villarreal FJ. Molecular interactions between matrilysin and the matrix metalloproteinase inhibitor doxycycline investigated by deuterium exchange mass spectrometry. Mol Pharmacol 67: 1128-1136, 2005.
23. Golub LM, Lee HM, Ryan ME, Giannobile WV, Payne J, and Sorsa T. Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv Dent Res 12: 12-26, 1998.
24. Han S, Espinoza LA, Liao H, Boulares AH, and Smulson ME. Protection by antioxidants against toxicity and apoptosis induced by the sulphur mustard analog 2-chloroethylethyl sulphide (CEES) in Jurkat T cells and normal human lymphocytes. Br J Pharmacol 141: 795-802, 2004.
25. Hoekstra R, Eskens F, and Verweij J. MMP inhibitors: current developments and future perspectives. Oncologist 6: 415-427, 2001.
26. Kaito K, Urayama H, and Watanabe G. Doxycycline treatment in a model of early abdominal aortic aneurysm. Surg Today 33: 426-433, 2003.
27. Koivunen AL, Maisi P, Konttinen YT, Prikk K, and Sandholm M. Collagenolytic activity and its sensitivity to doxycycline inhibition in tracheal aspirates of horses with chronic obstructive pulmonary disease. Acta Vet Scand 38: 9-16, 1997.
28. Kumar O, Sugendran K, and Vijayaraghavan R. Protective effect of various antioxidants on the toxicity of sulphur mustard administered to mice by inhalation or percutaneous routes. Chem Biol Interact 134: 1-12, 2001.
29. Lee KS, Jin SM, Kim SS, and Lee YC. Doxycycline reduces airway inflammation and hyperresponsiveness in a murine model of toluene diisocyanate-induced asthma. J Allergy Clin Immunol 113: 902-909, 2004.
30. Lindsay CD and Hambrook JL. Diisopropylglutathione ester protects A549 cells from the cytotoxic effects of sulphur mustard. Hum Exp Toxicol 17: 606-612, 1998.
31. Lindsay CD and Hambrook JL. Protection of A549 cells against the toxic effects of sulphur mustard by hexamethylenetetramine. Hum Exp Toxicol 16: 106-114, 1997.
32. Lindsay CD, Hambrook JL, Brown RF, Platt JC, Knight R, and Rice P. Examination of changes in connective tissue macromolecular components of large white pig skin following application of Lewisite vapour. J Appl Toxicol 24: 37-46, 2004.
33. Lindsay CD, Hambrook JL, and Lailey AF. Monoisopropylglutathione ester protects A549 cells from the cytotoxic effects of sulphur mustard. Hum Exp Toxicol 16: 636-644, 1997.
34. Liu H, Lightfoot R, and Stevens JL. Activation of heat shock factor by alkylating agents is triggered by glutathione depletion and oxidation of protein thiols. J Biol Chem 271: 4805-4812, 1996.
35. 14C]sulfur mustard in rats after intravenous exposure. Toxicol Appl Pharmacol 125: 281-287, 1994.
36. Mott JD and Werb Z. Regulation of matrix biology by matrix metalloproteinases. Cuir Opin Cell Biol 16: 558-564, 2004.
37. Nip LH, Uitto VJ, and Golub LM. Inhibition of epithelial cell matrix metalloproteinases by tetracyclines. J Periodontal Res 28: 379-385, 1993.
38. Nyska A, Lomnitski L, Maronpot R, Moomaw C, Brodsky B, Sintov A, and Wormser U. Effects of iodine on inducible nitric oxide synthase and cyclooxygenase-2 expression in sulfur mustard-induced skin. Arch Toxicol 768-774, 2001.
39. Papirmeister B, Feister AJ, Robinson SI, and Ford RD. Medical Defense Against Mustard Gas: Toxic Mechanisms and Pharmalogical Implications. Boca Raton, FL: CRC, 1991.
40. Petrinec D, Liao S, Holmes DR, Reilly JM, Paks WC, and Thompson RW. Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kDa gelatinase. J Vasc Surg 23: 336-346, 1996.
41. Requena L, Requena C, Sanchez M, Jacqueti G, Aguilar A, Sanchez-Yus E, and Hernandez-Moro B. Chemical warfare. Cutaneous lesions from mustard gas. J Am Acad Dermatol 19: 529-536, 1988.
42. Sabourin CL, Danne MM, Buxton KL, Casillas RP, and Schlager JJ. Cytokine, chemokine, and matrix metalloproteinase response after sulfur mustard injury to weanling pig skin. J Biochem Mol Toxicol 16: 263-272, 2002.
43. Sawyer TW. Characterization of the protective effects of L-nitroarginine methyl ester (L-NAME) against the toxicity of sulphur mustard in vitro. Toxicology 131: 21-32, 1998.
44. Sawyer TW. Synergistic protective effects of selected arginine analogues against sulphur mustard toxicity in neuron culture. Toxicol Appl Pharmacol 155: 169-176, 1999.
45. Shlopov BV, Stuart JM, Gumanovskaya ML, and Hasty KA. Regulation of cartilage collagenase by doxycycline. J Rheumatol 28: 835-842. 2001.
46. Siemonsma MA, de Hingh IH, de Man BM, Lomme RM, Verhofstad AA, and Hendriks T. Doxycycline improves wound strength after intestinal anastomosis in the rat. Surgery 133: 268-276, 2003.
47. Smith GN Jr, Mickler EA, Hasty KA, and Brandt KD. Specificity of inhibition of matrix metalloproteinase activity by doxycycline: relationship to structure of the enzyme. Arthritis Rheum 42: 1140-1146, 1999.
48. Tchetverikov I, Ronday HK, Van El B, Kiers GH, Verzijl N, Te-Koppele JM, Huizinga TW, DeGroot J, and Hanemaaijer R. MMP profile in paired serum and synovial fluid samples of patients with rheumatoid arthritis. Ann Rheum Dis 63: 881-883, 2004.
49. Urbannetti JS. Battlefield chemical inhalation injury. In: Pathophysiology and Treatment of Inhalation Injuries, edited by Loke J. New York: Dekker: 1988, vol. 34, chapt. 8, p. 281-348.
50. Vieillard-Baron A, Frisdal E, Raffestin B, Baker AH, Eddahibi S, Adnot S, and D'Ortho MP. Inhibition of matrix metalloproteinases by lung TIMP-1 gene transfer limits monocrotaline-induced pulmonary vascular remodeling in rats. Hum Gene Ther 14: 861-869, 2003.
51. Visse R and Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92: 827-839, 2003.
52. Wasil M, Halliwell B, and Moorhouse CP. Scavenging of hypoclorous acid by tetracycline, rifampicin and some other antibiotics: a possible antioxidant action of rifampicin and tetracycline? Biochem Pharmacol 37: 775-778, 1988.
53. Welgus HG, Campbell EJ, Bar-Shavit Z, Senior RM, and Teitelbaum SL. Human alveolar macrophages produce a fibroblast-like collagenase and collagenase inhibitor. J Clin Invest 76: 219-224, 1985.
54. Willems JL. Clinical management of mustard gas casualties. Ann Med Milit (Belg) 3 Suppl: 1-61, 1989.
55. Woessner JF, Dannenberg AM, Pula PJ, Selzer MG, Ruppert CL, Higuchi K, Kajiki A, Nakamura M, Dahms NM, Kerr JS, and Hart GW. Extracellular collagenase, proteoglycanase and products of their activity, released in organ culture by intact dermal inflammatory lesions produced by sulfur mustard. J Invest Dermatol 95: 717-726, 1990.